Synthpop vs Waystar

A DME supplier that already sends claims through Waystar and loses hours to payor hold times suits Synthpop's payor agent. The vendor says it writes each verification result back to the customer's system, and it lists Waystar among the billing and clearinghouse systems it works with, so the two can sit in one stack.

Waystar fits a hospital patient financial services team: claim and payer payment management, denial recovery, remittance, appeals and patient payments, from a company that went public in June 2024. Synthpop raised a US$15M Series A in February 2026 and shows MedBridge under "Trusted by". Its focus is eligibility, benefits, authorization, intake and patient outreach, which leaves the hospital's claims and denial queue to Waystar. Waystar's homepage shows HITRUST, SOC 2, PCI and HIPAA badges with no scope stated, and Synthpop's payor and compliance pages give its SOC 2 claim no type.